Health Professional Radio - Podcast

Zack Irani, CEO of Biomerica , a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products, discusses tools to make at-home screenings for diseases like breast cancer, colon cancer, etc. simple and easy. He talks about the new technology that's available, new screening guidelines, and why simple at-home tests and tools can he...

Dr. Joanne Armstrong, MD, MPH, Vice President and Chief Medical Officer, Women's Health and Genomics at CVS Health discusses the company’s commitment to support women as they face unique health challenges, in addition to often placing other’s needs before their own. #TeamCVS #HealthierHappensTogether #HereforHer Dr. Joanne Armstrong is responsible for women's health, genomics, and gene therapy str...

Returning guest, Dr. Harvey Kaufman,​ MD, FCAP,​ Senior Medical Director, Medical Informatics at Quest Diagnostics , the world's leading provider of diagnostic information services, discusses a new Quest Diagnostics Health Trends study, published in the Journal of Clinical Oncology, which shows that diagnosis of the two most common cancers – breast and prostate – remains down from pre-pandemic lev...

Kelly Heger, whose daughter has Aromatic L-amino Acid Decarboxylase deficiency or AADC deficiency, a rare and fatal genetic disorder, shares her story of getting medical training to care for her daughter and learning to navigate the medical system to get her daughter the care that she needed. Kelly's daughter is now 26 years old and Kelly advocates for and connects patients and caregivers around t...

Dr. Grayson Armstrong, MD, MPH, Director, Ophthalmology Emergency Service at Massachusetts Eye and Ear and Harvard Medical School Instructor in Ophthalmology and Associate Director of Medical Student Education discusses his study on Optimizing Telemedicine and AI for Eye Care that was presented at the 2022 American Academy of Ophthalmology (AAO) Annual Meeting. #AAO2022 Dr. Armstrong earned his MD...

Massachusetts Eye and Ear physician and surgeon, Dr. Michael Yoon, Ophthalmic Plastic Surgery and Ophthalmic Oncology | Fellowship Programs Leader for the Department of Ophthalmology discusses his study on 3-D Printing for Orbital Reconstruction After Trauma or Tumors that was presented at the 2022 American Academy of Opthalmology (AAO) Annual Meeting. #AAO2022 Dr. Michael Yoon is a member of the...

John Bracaglia, CEO and co-founder of Marvin , a company providing behavioral health services for healthcare professionals, shares his story and talks about why he launched Marvin. It has been reported that only 35% of healthcare workers show an improvement from a traditional depression and anxiety treatment program. Marvin’s trained therapists have the cultural competency to understand the demand...

Kaile Zagger, CEO of   Infinant  Health ,  previously known as Evolve Biosystems, discusses the importance of the infant microbiome and why their  product, EVIVO,  contains a specific strain of   B.  infantis,  EVC001 . #InfinantHealth Widely recognized as a Social Impact Leader and an expert in working to improve standards of care in healthcare, Kaile Zagge...

Jill Pellegrino, Vice President of Recruitment and Real World Evidence (RWE) at CVS Health Clinical Trial Services, discusses how CVS Health is leveraging its many resources to develop comprehensive real-world data and real-world evidence that complement clinical findings, revealing deeper insights into health and safety outcomes, efficacy of treatments, and patient and physician behaviors. #CVSHe...

Juliette Han, Chief Financial Officer and Chief Operating Officer at Cambrian BioPharma discusses the company's work in discovering treatments that increase healthspan and why people living longer would benefit the economy/society. She talks about the importance of the healthcare industry sharing clinical and experimental data transparently with one another to collectively solve healthcare issues...

Rob Graybill, SVP, Strategy & Business Development at Zelis , a healthcare payments and pricing company, discusses new research that shows over a third of households in most income brackets have “delayed or avoided medical care or purchasing of prescriptions” due to rising costs. He talks about the Transparency in Coverage Rule, how consumers can "shop" for healthcare, and how removing the mys...

Shriya Swaminathan, Science Policy Advisor at People for the Ethical Treatment of Animals (PETA) discusses the U.S. Navy's current use of sheep for decompression sickness/illness (DCS/DCI) experiments when there are other ways to research DCS/DCI. #PETA Shriya Swaminathan is a Science Policy Advisor at People for the Ethical Treatment of Animals (PETA), where she helps public universities, private...

Most drug developers seek new drug approvals in both the U.S. and Europe as they are two of the largest markets. However, considering both entities have some of the most evolved regulatory guidelines, approvals in the U.S. and Europe are often complicated by different policies, making simultaneous submissions of drug applications to multiple health authorities difficult and inefficient. Steve Sibl...

Dr. Christian Razo, MSc, PhD, Postdoctoral Fellow at the Institute for Health Metrics and Evaluation (IHME), discusses the findings of a study published in Nature Medicine (Oct 2022) that aims to clarify the often complex and contradictory health guidance linking certain diets, behaviors, and conditions to illness. #Diet #HealthHabits #NatureMedicine Christian Razo, MSc, PhD, is a Postdoctoral Fel...

Dr. Jathin Bandari, MD, Chief Medical Officer at Protara Therapeutics , a clinical-stage company committed to identifying and advancing transformative therapies for people with cancer and rare diseases, discusses non-muscle invasive bladder cancer (NMIBC) and the company's investigational cell therapy, TARA-002, that is currently in development for the treatment of NMIBC, which Protara believes ca...

CVS Health launched Clinical Trial Services (CTS) in mid-2021, with the aim of expanding clinical trial participation in previously underserved demographics, because a CVS retail location is no more than 10 miles from the majority of the American population. Dr. Owen Garrick, MD, Chief Medical Officer at CTS, discusses how the accessibility and flexibility of this decentralized model can address i...

Dr. Jonathan Wall, Co-Founder and Interim Chief Scientific Officer at Attralus discusses the latest developments in systemic amyloidosis research, stemming from its oral and poster presentations at the XVIII International Symposium on Amyloidosis (ISA), alongside updates around its recently initiated Phase 1 trial in its lead therapeutic candidate, AT-02. # Attralus Jonathan Wall is a Professor at...

Nima Farzan, CEO of Kinnate Biopharma Inc., a precision oncology company, discusses the company's investigational targeted cancer therapies which are designed to target validated oncogenic drivers for patients who are not served or severely underserved today, such as patients with solid tumors harboring BRAF and FGFR-driven alterations. # KinnateBiopharma Nima Farzan brings over two decades of exe...

Dr. Lauren Powell, M.P.A., Ph. D., Vice President, US Health Equity & Community Wellness at Takeda , a global, values-based, R&D-driven biopharmaceutical leader discusses the importance of improving health outcomes in the most marginalized communities, how Takeda plays a unique role as a collaborator and convener for health equity, and her passion for dismantling the roots of oppression th...

Dr. Amanda Dilger, MD, ENT surgeon at Mass Eye and Ear discusses climate change and otolaryngology with a focus on climate health, sustainability in healthcare, and surgeon advocacy. #OTOMTG22 Dr. Amanda Dilger is a fellowship-trained, comprehensive ENT surgeon at Mass Eye and Ear. Dr. Dilger earned her medical degree from Harvard Medical School and completed her residency training at Northwestern...

Dr. Mark Varvares, MD, FACS, Chief of Otolaryngology/Head and Neck Surgery at Mass Eye and Ear talks about his study on Head and Neck Surgeon Perception of Oral Tongue Depth of Invasion that was presented at the 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) annual meeting. #OTOMTG22 Specializing in head and neck ablative and reconstructive surgery, Dr. Mark Va...

Dr. Jonathan Sadeh, MD, MSc, Senior Vice President of Immunology and Fibrosis Development, Global Drug Development at Bristol Myers Squibb discusses the recent approval of SOTYKTU™ (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor with a unique mechanism of action, for the treatment of patients with moderate-to-severe plaque psoriasis who are candi...

Beverly Taylor, Head of Global Influenza Scientific Policy at CSL Seqirus discusses Avian influenza and its typical spread during migratory seasons and the current threat to human health based on national risk assessments. She talks about a recent abstract presented at the OPTIONS XI conference, the importance of global surveillance for avian flu and other influenza strains that could spark a pand...

Dr. Rahul Mehan, MD, Founder of East Valley Urology Center of Arizona, discusses enlarged prostate, its symptoms, and available  treatment options. He also talks about   Rezūm ™ Water Vapor Therapy, a non-surgical treatment for men 50 years or older that can be performed in a doctor’s office. #Rezum Rahul Mehan, MD, is the founder of East Valley Urology (EVU) Center in Mesa, Arizona, and...

Returning guest, Dr. Jan Wehkamp, MD, PhD, Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development , LLC discusses new STELARA  ® (ustekinumab) lo​​ng term efficacy and safety data in ulcerative colitis (UC) and new novel guselkumab & golimumab combination therapy data in UC that was presented at United European Gastro...